Cardiology
RSSArticles
-
Pharmacology Update: Ospemifene Tablets (Osphena)
A selective estrogen receptor modulator (SERM), also known as an estrogen agonist/antagonist, has been approved by the FDA for the treatment of dyspareunia (painful intercourse) in postmenopausal women. Ospemifene is manufactured by Penn Pharmaceuticals Services Ltd. and marketed by Shionogi Inc. as Osphena. -
ECG Review - Chest Pain and Pauses in Lead II
-
Internal Medicine Alert - Full July 15, 2013 Issue in PDF
-
Prolotherapy — A Neglected Treatment for Knee Osteoarthritis?
The injection of a dextrose solution in and around the knee (prolotherapy) is an alternative treatment for the pain of knee osteoarthritis. A randomized, controlled trial shows that prolotherapy is effective for long-term control of knee pain and improvement in knee function. -
Diminishing Returns with Long-term Steroids in COPD Exacerbations
Five days of steroid treatment was as effective as 14 days of treatment in preventing repeat exacerbations of COPD in patients presenting to the emergency department with COPD exacerbations. -
Clinical Briefs By Louis Kuritzky
-
Clinical Briefs By Louis Kuritzky, MD
A More Effective Regimen for H. pylori Eradication; Uric Acid: How Much of a Bad Guy?; The Word GPR40 Modulator May Soon be Entering Our Vocabulary -
Delayed Primary Epstein-Barr Virus Infection: Clinical and Immunologic Manifestations
A prospective study on Epstein-Barr virus seronegative college freshmen found that primary infection was symptomatic in 89% of cases. Kissing was the primary risk factor for infection, and blood viral load, CD8+ lymphocytosis, and IL-6 levels correlated with disease severity. -
Emergency Medicine Reports January 13, 2013 Issue in PDF
-
"I'm Swollen": Evaluation of Peripheral Edema in the Emergency Department
Case 1. A 53-year-old female presents to the emergency department with a 5-day history of generalized edema, primarily noted in her lower extremities.